Hikma Pharmaceuticals PLC (HIK.L)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2014||Chairman of the Board, Chief Executive|
|58||2014||Executive Vice Chairman of the Board, President and Chief Executive Officer of MENA and Emerging Markets|
|2011||Chief Financial Officer|
|2015||President, West-Ward Pharmaceuticals|
|2016||Chief Executive Officer, West-Ward Pharmaceuticals|
- RPT-BRIEF-Hikma enters into settlement agreement with Jazz
- BRIEF-Hikma enters into settlement agreement with Jazz
- BRIEF-Jazz Pharma settles Xyrem patent litigation with Hikma Pharma
- BRIEF-Hikma sees 2017 revenue to be around $2.2 bln
- D.C. Circuit refuses to revive Takeda appeal to block rival gout drug